Forte Biosciences, Inc. (FBRX)

$0.9798

-0.01 (-1.05%)
Rating:
Recommendation:
-
Symbol FBRX
Price $0.9798
Beta 1.567
Volume Avg. 0.05M
Market Cap 20.576M
Shares () -
52 Week Range 0.898-2.5
1y Target Est -
DCF Unlevered FBRX DCF ->
DCF Levered FBRX LDCF ->
ROE -30.36% Strong Sell
ROA -27.35% Sell
Operating Margin -
Debt / Equity 5.35% Neutral
P/E -0.72
P/B 0.43 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest FBRX news


Dr. Paul A. Wagner
Healthcare
Biotechnology
NASDAQ Capital Market

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.